AXS trades at 8x earnings and 6.8x forward earnings, which is a material discount for a firm generating a 13.30% ROIC and 15.40% operating margins. A PEG Forward of 0.3 implies the market is pricing growth at a fraction of its potential, especially with EPS expected to jump from 6.3 to 12.52 next year. At 1.3x book and 1.2x sales, this is not a speculative multiple but a balance-sheet-anchored valuation. The absence of an Altman Z-Score limits visibility into balance sheet distress risk, but the current pricing reflects deep skepticism rather than optimism. This looks like a statistically cheap compounder in a sector where stable underwriting profits should not command a single-digit multiple if growth materializes.